March 3, 2026Biomedical ReportsOpen Access

Efficacy and safety of mesenchymal stem cells for cerebral infarction: A meta‑analysis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Meta-analysis reveals mesenchymal stem cells improve outcomes in cerebral infarction, suggesting a promising treatment approach.

Mesenchymal stem cell therapy significantly improves the neurological deficit score and motor function in cerebral infarction patients.
Adverse effects such as fever and headache were mild and resolved quickly in most cases during the treatment.
Analysis included 19 randomized controlled trials, systematically searching multiple databases to ensure comprehensive findings.
Further studies are warranted for conclusive evidence, especially given the limited number of existing randomized trials.

Jiang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

March 3, 2026Biomedical ReportsOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Meta-analysis reveals mesenchymal stem cells improve outcomes in cerebral infarction, suggesting a promising treatment approach.

Mesenchymal stem cell therapy significantly improves the neurological deficit score and motor function in cerebral infarction patients.
Adverse effects such as fever and headache were mild and resolved quickly in most cases during the treatment.
Analysis included 19 randomized controlled trials, systematically searching multiple databases to ensure comprehensive findings.
Further studies are warranted for conclusive evidence, especially given the limited number of existing randomized trials.

Jiang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark